Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Myelofibrosis

Recruiting

InvestigationalNo placebo

Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drug

Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Elacestrant

Contact Research Centre

Rectal cancer+1

Recruiting

Registered drugNo placebo

Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Analgesic therapy

Recruiting

Registered drug

Study on Betamethasone Injection for Pain Relief in Adults with Degenerative Meniscal Injury

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Peripheral T-cell lymphoma unspecified

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Belinostat

Contact Research Centre

Mantle cell lymphoma

Recruiting

Registered drugNo placebo

Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cevostamab

Contact Research Centre

Acute leukaemia

Recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Revumenib

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

Registered drugNo placebo

Study on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Rectal cancer+2

Recruiting

Registered drugNo placebo

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Short-bowel syndrome

Recruiting

Investigational

Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

Investigational

France

Participants:18–64 years · 65+ years
Substances:Human Glucagon-Like Peptide-2 Analogue Linked To A Human Immunoglobulin Fc Fragment

Contact Research Centre

Find therapies in clinical trials near you – page 13

648 trials match your criteria

Myelofibrosis

Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

Hormone receptor positive HER2 negative breast cancer

Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Rectal cancer+1

Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

Analgesic therapy

Study on Betamethasone Injection for Pain Relief in Adults with Degenerative Meniscal Injury

Peripheral T-cell lymphoma unspecified

Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

Mantle cell lymphoma

Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

Plasma cell myeloma

Study on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma

Acute leukaemia

Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

Neoplasm

Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Gastrooesophageal cancer+1

Study on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer

Rectal cancer+2

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Short-bowel syndrome

Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.